Client and Provider Preferences for HIV Care

Client and Provider Preferences for HIV Care: Implications for Implementing Differentiated Service Delivery in Thailand

This study will investigate preferences for HIV care among participants enrolled in the "Study to evaluate the feasibility of Community-based Test and Treat strategies among men who have sex with men and transgender women to increase the uptake of HIV testing and treatment services in Thailand" through a model involving linked strategies: The study takes place in four provinces at six sites affiliated with the Thai Red Cross AIDS Research Center (TRCARC): Bangkok (RSAT and SWING), Chiang Mai (CAREMAT), Chonburi (SWING and Sisters) and Songkhla (RSAT). These are all community-based drop-in centers, targeting MSM and TGW.

Participants who are enrolled in the study at any of the TRCARC affiliated sites and who were tested HIV-positive will be invited to participate in the current questionnaire study.

Study Overview

• Status: Completed
• Conditions: HIV Infections
• Intervention / Treatment: Other: questionnaires survey

Detailed Description

This will be a cross-sectional questionnaire study. A self-administered questionnaire will be used to assess their satisfaction with current clinical services, preferences for location, frequency and provider of HIV services, as well as expectations and concerns.

Furthermore, staff working at the different HIV-care to community-based organizations (CBOs) and the health care workers providing HIV services will be invited to participate as well. They will also be asked to complete a self-administered questionnaire to assess knowledge and attitude, preferences for location, frequency and provider of HIV services, as well as expectation and concerns.

All data collected, from patients, as well as from staff, will be anonymous.

• Study Type: Observational
• Enrollment (Actual): 370

Contacts and Locations

Study Locations

• Thailand
  • Bangkok, Thailand, 10330
    • The Thai Red Cross AIDS Research Centre

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

Men who have Sex with Men or Transgender women who have been tested HIV-positive in the Community Led Test and Treat Study and are receiving ART.

Description

Inclusion Criteria:

• Enrolled in the Community Led Test and Treat Study at either RSAT or SWING
• According to the inclusion criteria of the Community Led Test and Treat Study, participants will be at least 18 years of age
• HIV-infected and receiving ART
• Willing to participate in the survey

Exclusion Criteria:

N/A

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Preferences for differentiated models of service delivery	A self-administered questionnaire was developed to assess preferences for location, frequency and provider for different aspects of HIV care. For HIV-care to community-based organizations staff and health care workers, additional questions regarding attitudes and knowledge regarding differentiated service delivery will be included.	6 months

Collaborators and Investigators

• Sponsor: Thai Red Cross AIDS Research Centre
• Investigators: Principal Investigator: Nittaya Phanuphak, MD, PhD, Thai Red Cross AIDS Research Centre (TRCARC)

Study record dates

Study Major Dates

• Study Start (Actual): July 15, 2017
• Primary Completion (Actual): December 15, 2021
• Study Completion (Actual): July 15, 2022

Study Registration Dates

• First Submitted: June 23, 2017
• First Submitted That Met QC Criteria: July 12, 2017
• First Posted (Actual): July 13, 2017

Study Record Updates

• Last Update Posted (Actual): November 25, 2024
• Last Update Submitted That Met QC Criteria: November 22, 2024
• Last Verified: November 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Blood-Borne Infections; Urogenital Diseases; Genital Diseases; Immune System Diseases; Infections; RNA Virus Infections; Virus Diseases; Communicable Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; Immunologic Deficiency Syndromes; HIV Infections
• Other Study ID Numbers: Client & Provider Preferences

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No